(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD

BPC-157 & Thymosin Beta 4 Capsules

BPC-157 Thymosin Beta 4 Blended Capsules Bulgaria are prominent peptides for wound healing and tissue repair. BPC-157 Arginate and TB-500 reduce inflammation and oxidative stress, protect neurons, and enhance tissue repair cell migration, increasing nervous system health. These two peptides are also being studied in traumatic brain injury, stroke, ALS, and Alzheimer’s.


SKU PG: BPC-157 & Thymosin Beta 4 Capsules Categories , , , ,

495 in stock


BPC-157 Thymosin Beta 4 Blended Capsules Bulgaria

BPC-157 Thymosin Beta 4 Blended Capsules, despite the fact that BPC-157 Arginate Salt and Thymosin Beta 4 can accelerate regeneration and recovery, their mechanisms of action are distinct. BPC-157 is the peptide that is least understood. It is an active peptide in intestinal and nervous system as well as being beneficial to muscle and tendon injuries, according to Bulgaria research. It has both anti-inflammatory and angiogenic properties. Researchers are dubious of the precise mechanism by which BPC 157 operates, but they do know that it improves fibroblast activity and, consequently, the generation and maintenance of the extracellular matrix.

Ac-SDKP derives from a 4-amino-acid, whereas TB-500 is derived from Thymosin Beta 4. Ac-SDKP and TB500 share comparable functional characteristics. Both are essential for processes such as angiogenesis and cell migration. Ac-SDKP can accelerate endothelial cell migration, whereas TB-500 activates these cells so that they can conduct wound repair. However, unlike TB500 and Thymosin Beta 4, Ac-SDKP does not stimulate the movement of stem cells. The Ac-SDKP fragment of Thymosin Beta 4 stops the stem cells from changing into cells other than endothelial and blood vessel cells. This property may be relevant to the study of cancers that are not caused by endothelial cell carcinoma.

In general, the benefits of BPC-157 Thymosin Beta 4 capsules are attributable to the fact that these two peptides influence the same cells in slightly different ways. Ac-SDKP and TB-500, which are derivatives of Thymosin beta 4, enhance cell migration and cell motility. The rate-limiting phase in tissue restoration is the capacity of cells types such as fibroblasts to reach injury sites. Many of these cells die before they reach their destination or simply don’t last long once they arrive, so it is highly advantageous to increase their mobility.

There is Bulgaria research potential for these peptides, when used in the proper combination and for the appropriate durations, to promote healing in neurodegenerative diseases, inflammatory diseases, infections, and injuries. However further research is required to establish how the combination can effect human subjects.

Benefits of BPC-157 Thymosin Beta 4 Blended Capsules Bulgaria

Research has indicated that BPC-157 Thymosin Beta 4 Blended Capsules could offer the following benefits:

  • Reduces inflammation
  • Increases the rate of repair in muscles and tissues
  • Potential treatment of neurological disorders
  • Accelerates the regeneration of cells
  • Restores joint and bone health
  • Reduces injury time


The anti-inflammatory peptide Ac-SDKP: Synthesis, role in ACE inhibition, and its therapeutic potential in hypertension and cardiovascular diseases – ScienceDirect

Ac-SDKP inhibits transforming growth factor-β1-induced differentiation of human cardiac fibroblasts into myofibroblasts – PMC (nih.gov)


PLEASE NOTE: We do not supply Peptides or Sarms to any individual under the age of 18. You must be a licensed and qualified healthcare practitioner. All products listed on this website (https://pharmagrade.store) and provided through Pharma Grade are intended ONLY FOR medical research purposes. Pharma Grade does not encourage or promote the use of any of these products in a personal capacity (i.e. human consumption) nor are the products intended as a drug, stimulant or for use in any food products.